Biopharmaceutical Manufacturing

Predefined Single-Use Production Platforms for Biomanufacturing

The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines, and bioconjugates.

Companies can streamline early-stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late-stage activities using process templates that reduce design costs and increase standardization.

Racing for a Viable Vaccine: Expediting Vaccine Development Amidst a Pandemic
Fight the Coronavirus

Sartorius Biomanufacturing Platforms

Vaccines

Learn More

Blood and Plasma

Discover our Technologies for Plasma Fractionation and Recombinant Blood Factors

Learn More

Bioconjugation

Learn More

Regenerative Medicine

Learn More

Biosimilars

Learn More

Intensified Processing

Learn More

Cell Line Development Toolbox for Intensified Bioprocessing | Dec 8

Learn how our toolbox can help you to speed up process development

Register Now

Sartorius End-to-End, Single-Use Downstream Solution | December 1

Learn how Sartorius' new, single-use technologies meet the growing demands of clinical and commercial biopharmaceutical environments.

Register Now for Webinar
Publication: A Look into the Future of Bioprocessing
Download Now

Explore Sartorius

Bioprocess Development Engineering

Learn More

Expert Voice, Publications and Case Studies

Learn More

Sartorius Application Center

Learn More